Clinical Trial Update: Evolocumab in Patients With Multivessel Coronary Disease After Acute Myocardial Infarction: A Target Trial Emulation

View source ↗

Summary

This document provides an update on a trial evaluating evolocumab in patients with multivessel coronary artery disease after acute myocardial infarction, using …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multivessel Coronary Artery Disease
• Myocardial Infarction

Drugs mentioned

• Evolocumab (evolocumab)

Snippet

Sponsor: Shanghai Zhongshan Hospital | Conditions: Multivessel Coronary Artery Disease, Acute Myocardial Infarction (AMI) | Status: COMPLETED